Does Singapore have the PCV20 vaccine and will it replace PCV13 as recommended in US? If it is available, why is it not subsidised?
PCV20 vaccine was approved for use in Singapore in November 2022. From September 2025, PCV20 vaccine will be included in the National Adult Immunisation Schedule (NAIS) and the Subsidised Vaccine List (SVL).
Hence, subsidies for the PCV20 vaccine will be extended to eligible Singaporeans and Permanent Residents in the recommended groups from September 2025. From 2026, MediSave can be used to pay for the cost of the vaccine after subsidies.
More information on the clinical recommendation for pneumococcal vaccines in the NAIS will be available nearer to the implementation date. In the meantime, you may wish to consult your attending physician to discuss the most suitable pneumococcal vaccines for your condition.
Related questions
Why is shingles vaccination not subsidised? Can you provide subsidies for shingles vaccination?
What is the cost of the pneumococcal vaccination for adults aged 18 years old and above?
Which vaccines are approved for use in Singapore? Which of these vaccines are included in the national vaccination programme?
If vaccination is needed, are the vaccinations subsidised by MOH? If not, will the personnel be eligible for the National Adult Immunisation Schedule (NAIS) subsidy for the measles and diphtheria vaccination?
Need more help?
Get in touch